HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells
Creators
- 1. Key Laboratory of Molecular Biology, Hainan Medical College, Haikou, 571199 P.R. (China)
- 2. Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, 571199 , Hainan Province P.R. (China)
- 3. Department of Pathophysiology, Hainan Medical College, Haikou, 571199 P.R. (China)
- 4. Department of Physiology, Hainan Medical College, Haikou, 571199 P.R. (China)
- 5. Institution of Tumor, Hainan Medical College, Haikou, 571199 P.R. (China)
Description
Hepatitis B virus (HBV)-X protein(HBx) is a transactivator of host several cellular genes including alpha-fetoprotein(AFP) and AFP receptor(AFPR) which contributes to HBV-associated tumor development. The expression of AFP/AFPR are correlated with hepatocellular carcinoma(HCC)-initial cells. But the role of AFP and AFPR in promoting occurrence of HBV-related HCC were still unclear. A total of 71 clinical patients' liver specimens, normal human liver cells L-02 and HCC cell lines, PLC/PRF/5 were selected for analyzing the effects of HBx on expression of AFP, AFPR and Src. The expression of goal proteins were detected by Immunohistochemical stained and Western blotting; HBx-expressed vectors were constructed and transfected into L-02 cells, laser confocal microscopy was applied to observe expression and location of AFP, AFPR and Src in the normal liver cells and HCC cells, soft agar colony formation assay was used to observe colonies formed of the cells. We confirmed HBx gives preference to promote the expression of AFP and AFPR; HBx priors to up-regulate the expression of AFPR and AFP in L-02 cells and in normal liver specimens; AFPR signal been able to stimulate Src expression. The results also indicated that phosphatidylinositol 3-kinase(PI3K) inhibitors Ly294002 and GDC0941 effectively suppress AFPR mediated up-regulation expression of Src in AFPR positive HCC lines. HBx priors to drive the expression of AFP and AFPR to promote expression of Src in normal liver cells and hepatoma cells; AFP and AFPR maybe play pivotal role in HBV-related hepatocarcinogenesis; Targeting AFPR is an available therapeutic strategy of HCC. The online version of this article (doi:10.1186/s12885-015-1384-9) contains supplementary material, which is available to authorized users
Availability note (English)
Available from http://dx.doi.org/10.1186/s12885-015-1384-9; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427932Additional details
Identifiers
Publishing Information
- Journal Title
- BMC cancer (Online)
- Journal Volume
- 15
- Journal Page Range
- [0 p.]
- ISSN
- 1471-2407
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46124048
- Subject category
- S60: APPLIED LIFE SCIENCES; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COLONY FORMATION; HEPATITIS; HEPATOMAS; LIVER CELLS; RECEPTORS; SIGNALS
- Descriptors DEC
- ANIMAL CELLS; CARCINOMAS; DIGESTIVE SYSTEM DISEASES; DISEASES; MEMBRANE PROTEINS; NEOPLASMS; ORGANIC COMPOUNDS; PROTEINS; SOMATIC CELLS
Optional Information
- Copyright
- Copyright (c) Zhu et al.
- Notes
- PMCID: PMC4427932; PMID: 25943101; PUBLISHER-ID: 1384; OAI: oai:pubmedcentral.nih.gov:4427932; licensee BioMed Central. 2015